ICON Public Limited Company Profile Avatar - Palmy Investing

ICON Public Limited Company

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, manage…
Medical - Diagnostics & Research
IE, Dublin [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 33% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.05 1.21 1.21
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -12.89 7.17 8.23
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.85 114.23 112.15
Cash 4.50 4.82 4.61
Capex 47.27 -0.33 -0.62
Free Cash Flow -20.78 3.63 4.58
Revenue 0.95 25.31 25.08
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.35 0.22 0.23
Operating Margin 5.04 0.14 0.13
ROA -13.69 0.01 0.01
ROE -15.15 0.02 0.02
ROIC -19.81 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ICLR is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ICLR is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ICLR is permitted for members.
End of ICLR's Analysis
CIK: 1060955 CUSIP: G4705A100 ISIN: IE0005711209 LEI: - UEI: -
Secondary Listings
ICLR has no secondary listings inside our databases.